lamivudinehttp://www.unboundmedicine.com/medline/ebm/research/lamivudineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Therapeutic strategies for chronic hepatitis B virus infection in 2008.http://www.unboundmedicine.com/medline/ebm/record/19185073/full_citation/Therapeutic_strategies_for_chronic_hepatitis_B_virus_infection_in_2008_Khokhar A, Afdhal NH 
Therapeutic strategies for chronic hepatitis B virus infection in 2008. [Journal Article]
Am J Med 2008 Dec; 121(12 Suppl):S33-44.
Abstract | Full Citation | Find Related Articles Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant Hepatitis B Virus e Antigen-positive and -negative strains.http://www.unboundmedicine.com/medline/ebm/record/19889778/full_citation/Differential_impact_of_immune_escape_mutations_G145R_and_P120T_on_the_replication_of_lamivudine_resistant_Hepatitis_B_Virus_e_Antigen_positive_and__negative_strains_Amini-Bavil-Olyaee S, Vucur M, Luedde T, et al. 
Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant Hepatitis B Virus e Antigen-positive and -negative strains. [JOURNAL ARTICLE]
J Virol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Viral hepatitis and HIV Co-Infection.http://www.unboundmedicine.com/medline/ebm/record/19887087/full_citation/Viral_hepatitis_and_HIV_Co_Infection_Soriano V, Vispo E, Labarga P, et al. 
Viral hepatitis and HIV Co-Infection. [JOURNAL ARTICLE]
Antiviral Res 2009 Oct 31.
Abstract | Full CitationPENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection.http://www.unboundmedicine.com/medline/ebm/record/19878352/full_citation/PENTA_2009_guidelines_for_the_use_of_antiretroviral_therapy_in_paediatric_HIV_1_infection_ 
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. [Journal Article]
HIV Med 2009 Nov; 10(10):591-613.
Abstract | Full Citation | Find Related Articles [Early prediction of lamivudine response in e antigen-negative chronic hepatitis B patients.]http://www.unboundmedicine.com/medline/ebm/record/19874689/full_citation/[Early_prediction_of_lamivudine_response_in_e_antigen_negative_chronic_hepatitis_B_patients_]Li JG, Li JX, Liu MX, et al. 
[Early prediction of lamivudine response in e antigen-negative chronic hepatitis B patients.] [English Abstract, Journal Article]
Zhonghua Gan Zang Bing Za Zhi 2009 Oct; 17(10):745-9.
Abstract | Full Citation | Find Related Articles Antiretroviral Strategies to Prevent Mother-to-Child Transmission of HIV: Striking a Balance between Efficacy, Feasibility, and Resistance.http://www.unboundmedicine.com/medline/ebm/record/19859532/full_citation/Antiretroviral_Strategies_to_Prevent_Mother_to_Child_Transmission_of_HIV:_Striking_a_Balance_between_Efficacy_Feasibility_and_Resistance_Lehman DA, John-Stewart GC, Overbaugh J 
Antiretroviral Strategies to Prevent Mother-to-Child Transmission of HIV: Striking a Balance between Efficacy, Feasibility, and Resistance. [JOURNAL ARTICLE]
PLoS Med 2009 Oct; 6(10):e1000169.
Abstract | Full Citation | Find Related Articles Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial.http://www.unboundmedicine.com/medline/ebm/record/19859531/full_citation/Efficacy_of_Short_Course_AZT_Plus_3TC_to_Reduce_Nevirapine_Resistance_in_the_Prevention_of_Mother_to_Child_HIV_Transmission:_A_Randomized_Clinical_Trial_McIntyre JA, Hopley M, Moodley D, et al. 
Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial. [JOURNAL ARTICLE]
PLoS Med 2009 Oct; 6(10):e1000172.
Abstract | Full Citation | Find Related Articles Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens.http://www.unboundmedicine.com/medline/ebm/record/19852859/full_citation/Five_year_follow_up_of_genotypic_resistance_patterns_in_HIV_1_subtype_C_infected_patients_in_Botswana_after_failure_of_thymidine_analogue_based_regimens_Doualla-Bell F, Gaolathe T, Avalos A, et al. 
Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens. [JOURNAL ARTICLE]
J Int AIDS Soc 2009 Oct 25; 12(1):25.
Abstract | Full CitationMonotherapy versus combination therapy for the treatment of chronic hepatitis B.http://www.unboundmedicine.com/medline/ebm/record/19852566/full_citation/Monotherapy_versus_combination_therapy_for_the_treatment_of_chronic_hepatitis_B_Carey I, Harrison PM 
Monotherapy versus combination therapy for the treatment of chronic hepatitis B. [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Oct 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Safety and efficacy of telbivudine for the treatment of chronic hepatitis B.http://www.unboundmedicine.com/medline/ebm/record/19851526/full_citation/Safety_and_efficacy_of_telbivudine_for_the_treatment_of_chronic_hepatitis_B_Osborn MK 
Safety and efficacy of telbivudine for the treatment of chronic hepatitis B. [Journal Article]
Ther Clin Risk Manag 2009.:789-98.
Abstract | Full Citation | Find Related Articles